SELECT * FROM `stock_list` where symbol='MOR' AND exchange = 'WBO' limit 0,1
SELECT * FROM `stock_list` where symbol='MOR' AND exchange = 'WBO' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "MOR" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 MorphoSys AG (WBO:MOR) Institutional Ownership
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MorphoSys AG (WBO:MOR) » Definitions » Institutional Ownership

MorphoSys AG (WBO:MOR) Institutional Ownership : 15.03% (As of May. 01, 2024)


View and export this data going back to 2017. Start your Free Trial

What is MorphoSys AG Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MorphoSys AG's institutional ownership is 15.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MorphoSys AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MorphoSys AG's Float Percentage Of Total Shares Outstanding is 89.02%.

MorphoSys AG Institutional Ownership Historical Data

The historical data trend for MorphoSys AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MorphoSys AG Institutional Ownership Chart

MorphoSys AG Historical Data

The historical data trend for MorphoSys AG can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 14.26 14.13 14.50 14.52 16.37 18.44 16.20 15.62 13.63 15.03

MorphoSys AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

MorphoSys AG (WBO:MOR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MorphoSys AG (WBO:MOR) » Definitions » Institutional Ownership
Comparable Companies
XTER:FYB XTER:HPHA XTER:MDG1 XTER:T5O OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB ALNY BGNE BMRN RPRX SRPT
Traded in Other Exchanges
MPSYF:USA MOR:USA 1MOR:Italy MORd:UK 0NDV:UK MOR:Germany
Address
Semmelweisstrasse 7, Planegg, BY, DEU, 82152
Website
https://www.morphosys.com
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.